Back to search

Article

CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuit

2024-03-01

Abstract excerpt

Chimeric antigen receptor (CAR)-engineered T and NK cells can cause durable remission of B-cell malignancies; however, limited persistence restrains the full potential of these therapies in many patients. The FAS ligand (FAS-L)/FAS pathway governs naturally-occurring lymphocyte homeostasis, yet knowledge of which cells express FAS-L in patients and whether these sources compromise CAR persistence remains incomplet...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
48d0caaa-e602-51e9-b798-cb445fc93efc
DOI
10.1101/2024.02.26.582108
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuitDOI 10.1101/2024.02.26.582108
Select a neighboring publication to make it the new centre.